Johnson & Johnson announced plans to spin off its orthopedics division into a new company called DePuy Synthes, aiming to focus on other healthcare sectors; the company reported strong Q3 earnings with sales beating estimates and raised its full-year sales guidance, with the separation expected to complete in 18-24 months.
Johnson & Johnson announced plans to spin off its DePuy Synthes Orthopaedics business to enhance focus and growth, creating a standalone orthopaedics company expected to be the largest in its field, with a strategic move aimed at boosting margins and market share, led by newly appointed president Namal Nawana.
Johnson & Johnson plans to spin off its Orthopaedics business into a standalone company called DePuy Synthes to focus on high-growth healthcare areas, improve margins, and enhance innovation, with the process expected to complete within 18-24 months.